HIGHLIGHTS
- who: James R. Janopaul-Naylor and collaborators from the Hopkins Medicine, United States Sungkyunkwan University have published the Article: Definitive intensity modulated proton re-irradiation for lung cancer in the immunotherapy era, in the Journal: (JOURNAL)
- what: The authors report the institutional experience with definitive intent reirradiation using Intensity Modulated Proton Therapy (IMPT). The authors evaluated the safety and efficacy of definitive intent re-irradiation using IMPT in the era of immunotherapy. The authors showed that for 22 patients with locoregionally recurrent or second primary NSCLC or SCLC that definitive intent IMPT was safe and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.